Liver Fibrosis Scores and Atrial Fibrillation Incidence in Heart Failure with Preserved Ejection Fraction
Authors:
Open Access
- 22 August 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 9 (6) , 3985-3994
Abstract
Aim: Non-alcoholic fatty liver disease (NAFLD)-related advanced liver fibrosis (Stage 3 or 4) was reported to be linked to worse prognosis in patients with heart failure with preserved ejection fraction (HFpEF). This study aims to assess the relationship between liver fibrosis scores and new-onset atrial fibrillation (AF) incidence in patients with HFpEF in the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial. Methods and results: Baseline liver fibrosis levels, assessed by NAFLD fibrosis score (NFS) or Fibrosis-4 index (FIB-4), with AF incidence were expressed as hazard ratios (HRs) using the Cox proportional hazard model. The risk for advanced fibrosis was estimated to be 21.5% (447/2072) as assessed by FIB-4 (>3.25) and 4.2% (88/2072) as assessed by NFS (>0.676) in HFpEF patients without baseline AF. After a median follow-up of 3.11 years, 106 new-onset AF cases occurred. In multivariate analysis, elevated NFS [NFS = −1.455–0.676: HR 2.44, 95% confidence interval (CI) 1.27–4.68; NFS > 0.676: HR 3.36, 95% CI 1.27–6.80; per 1 unit increase: HR 1.15, 95% CI 1.01–1.32], not FIB-4 (FIB-4 = 1.45–3.25: HR 1.02, 95% CI 0.67–1.55; FIB-4 > 3.25: HR 1.69, 95% CI 0.76–3.79; per 1 unit increase: HR 1.13, 95% CI 0.93–1.37), was associated with increased AF incidence. The NFS (C-index 0.662), not FIB-4 (C-index 0.531), had a moderate predictive ability in predicting incident AF. Conclusions: Among patients with HFpEF, the risk of advanced liver fibrosis is associated with an increased incidence of new-onset AF and may be a novel predictor for new-onset AF. Additional studies are needed to confirm our results.Keywords
Funding Information
- National High Technology Research and Development Program of Guangzhou (20180304001)
- National High Technology Research and Development Program of Guangzhou (2019GZR110406004)
- National High Technology Research and Development Program of Guangzhou (201704020044)
- Natural Science Foundation of Guangdong Province (2019A1515011682)
- National Natural Science Foundation of China (82070237)
- National Natural Science Foundation of China (81770229)
- National Natural Science Foundation of China (82100347)
- National Natural Science Foundation of China (81870170)
- National Natural Science Foundation of China (81970200)
- Natural Science Foundation of Guangdong Province (2019A1515011682)
- National Natural Science Foundation of China (82070237)
- National Natural Science Foundation of China (81770229)
- National Natural Science Foundation of China (82100347)
- National Natural Science Foundation of China (81870170)
- National Natural Science Foundation of China (81970200)
This publication has 46 references indexed in Scilit:
- Galectin 3 and incident atrial fibrillation in the communityAmerican Heart Journal, 2014
- Role of the Autonomic Nervous System in Modulating Cardiac ArrhythmiasCirculation Research, 2014
- Ionic Mechanisms Underlying the Effects of Vasoactive Intestinal Polypeptide on Canine Atrial MyocardiumCirculation: Arrhythmia and Electrophysiology, 2013
- APRI, the FIB-4 score, and Forn’s index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis BEuropean Journal of Gastroenterology & Hepatology, 2013
- Influence of Non-Alcoholic Fatty Liver Disease on Autonomic Changes Evaluated by the Time Domain, Frequency Domain, and Symbolic Dynamics of Heart Rate VariabilityPLOS ONE, 2013
- Myofibroblast-mediated mechanisms of pathological remodelling of the heartNature Reviews Cardiology, 2012
- Inducibility of Atrial Fibrillation After GP Ablations and “Autonomic Blockade”: Evidence for the Pathophysiological Role of the Nonadrenergic and Noncholinergic NeurotransmittersJournal of Cardiovascular Electrophysiology, 2012
- Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severityAnnals of Medicine, 2010
- Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseasesLiver International, 2008
- Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis CJournal of Hepatology, 2007